The downgrade reflects Moody’s expectation that Baxter will maintain margins at a lower level, and liquidity will grow slowly.
The rating outlook has been revised from negative to stable.
More articles on healthcare finance:
How CHS, Tenet, HCA and UHS fared in Q4
Temple University Health System’s operating loss narrows to $26.2M
Oklahoma hospital operator ousted over ‘immediate threat’ to patient safety
